SKIP TO
CONTENT
Philips Recalled CPAP, Bi-Level PAP, and Mechanical...
featured news
August 26, 2015
Healthcare Fraud
Medical Device Manufacturer NuVasive Agrees to Settle False Claims Act Allegations
The publicly-traded company known as NuVasive, Inc. has agreed to pay $13 million to settle claims it fraudulently induced doctors and healthcare professionals to overbill government programs like Medicare and Medicaid. The company, which is based in California, is known for its design, manufacture, and sale of products used in complex […]
August 25, 2015
Healthcare Fraud
Pediatric Services of America Settles False Claims Act Allegations for $6.88 Million
Under the False Claims Act, sins of omission are punished just as severely as sins of commission, and Pediatric Services of America can attest to this fact. Known as reverse false claims, failing to properly reimburse programs like Medicare and Medicaid for known overpayments is considered equivalent to overbilling and […]
August 20, 2015
Healthcare Fraud
Tennessee Hospital Agrees to Settle Allegations of False Billing and Unlawful Practices
Of the various ways in which healthcare providers can violate the False Claims Act, ordering medically unnecessary procedures – particularly those involving the cardiac system – are considered particularly egregious. As opposed to illegal upcoding or kickback schemes, the performance of medically unnecessary procedures actually places patients directly in harm’s […]
August 19, 2015
Healthcare Fraud
Government Accountability Office Alerts Congress to Medicare & Medicaid Eligibility Issues
In fiscal year 2014, American taxpayers footed a $554 billion dollar bill for Medicare and Medicaid – two programs that, while essential in nature, are exceedingly strapped for resources. As one of the hallmark goals of the False Claims Act, authorities have worked diligently to ensure providers are billing correctly […]
August 13, 2015
Healthcare Fraud
Berger Montague Settles Whistleblower Lawsuit Involving AstraZeneca, Cephalon, & BioGen, Inc.; Secures $55 Million on Behalf of Taxpayers
As one of the leading and most successful whistleblower law firms in the United States, Berger Montague is pleased to announce its involvement in a $55.5 million settlement involving three major players in the pharmaceutical industry. This past July, Berger Montague announced the settlement against AstraZeneca, Cephalon, Inc., and BioGen, […]
schedule a free consultation
"*" indicates required fields
By clicking SUBMIT you agree to our Terms of Use and Privacy Policy and you are providing express consent to receive communications from Berger Montague via calls, emails, and/or text messages.
$50B+
in Settlements & Verdicts
53+
Years of High-Profile Cases
100+
Attorneys Protecting Your Rights
2X
Named “Trial Lawyer of the Year”
50
States in Which The Firm Has Successfully Litigated Cases
On the Cutting Edge of the Profession
Legal Intelligencer
53
Years
